Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable glycylpeptide N-tetradecanoyltransferase activity and peptidyl-lysine N6-myristoyltransferase activity. Predicted to be located in Golgi apparatus; cytosol; and plasma membrane. Predicted to be active in cytoplasm. Is expressed in several structures, including central nervous system; genitourinary system; gut; hemolymphoid system gland; and liver. Orthologous to human NMT2 (N-myristoyltransferase 2).